Moshe Chaim Ornstein
Cleveland Clinic(US)Cancer Institute (WIA)(IN)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Cancer Genomics and Diagnostics, Renal and related cancers
Most-Cited Works
- → Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma(2018)181 cited
- → Clinical Review on the Management of Metastatic Renal Cell Carcinoma(2021)142 cited
- An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS.(1985)
- → Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study(2019)99 cited
- → Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors(2020)94 cited
- → Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target(2018)78 cited
- → State of the evidence: mechanical ventilation with PEEP in patients with cardiogenic shock(2013)69 cited
- → Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab(2018)67 cited
- → Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma(2019)67 cited
- → Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook(2018)63 cited